Guanze Medical Information Industry (Holding) Co., Ltd. has issued a circular convening its annual general meeting for 10:00 a.m. on 29 May 2026 in Central, Hong Kong.

The board will seek shareholder approval for three capital mandates:

1. Issue Mandate – Directors may allot, issue or transfer up to 190.00 million new or treasury shares, equal to 20% of the current 950.00 million issued shares. 2. Repurchase Mandate – The company may buy back up to 95.00 million shares, representing 10% of the existing share capital. 3. Extension Mandate – The issue limit may be increased by the number of shares actually repurchased under the buy-back authority.

The directors state they have no immediate plans to exercise either mandate.

Governance items include the proposed re-election of independent non-executive directors Dr. Chang Shiwang and Dr. Wong Man Hin Raymond, each serving three-year terms, and the reappointment of Moore CPA Limited as auditor.

The share register will close from 26 May to 29 May 2026, with 25 May 2026 set as the last day for share transfers to qualify for AGM voting rights. Proxy forms must be lodged at Computershare Hong Kong Investor Services by 10:00 a.m. on 27 May 2026.